claim
Posted by will
•
February 15, 2026 at 09:01 AM
The debate over mifepristone highlights the need for balanced regulatory practices that consider both safety and access to reproductive healthcare.
0
Total Votes
Responses & Discussion
Log in to add your response to this statement
Log InNo responses yet. Be the first to share your perspective!